Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 9 | 2022 | 384 | 1.150 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2011 | 11 | 0.750 |
Why?
|
| Braces | 2 | 2014 | 10 | 0.730 |
Why?
|
| Hospitals | 2 | 2023 | 373 | 0.680 |
Why?
|
| Intestinal Obstruction | 3 | 2012 | 47 | 0.660 |
Why?
|
| Surgeons | 4 | 2023 | 156 | 0.640 |
Why?
|
| Urinary Tract Infections | 2 | 2011 | 75 | 0.620 |
Why?
|
| Child | 27 | 2023 | 4243 | 0.610 |
Why?
|
| Appendicitis | 3 | 2018 | 73 | 0.590 |
Why?
|
| Child, Preschool | 16 | 2018 | 1814 | 0.510 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.460 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 20 | 0.410 |
Why?
|
| Infant | 14 | 2022 | 1509 | 0.410 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 33 | 0.400 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 263 | 0.390 |
Why?
|
| Bites and Stings | 1 | 2011 | 10 | 0.390 |
Why?
|
| Cicatrix | 2 | 2011 | 58 | 0.380 |
Why?
|
| Facial Injuries | 1 | 2011 | 14 | 0.380 |
Why?
|
| Specialties, Surgical | 2 | 2023 | 44 | 0.380 |
Why?
|
| Wound Infection | 1 | 2011 | 22 | 0.380 |
Why?
|
| Colectomy | 1 | 2012 | 96 | 0.380 |
Why?
|
| Dextrans | 2 | 2009 | 44 | 0.370 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 63 | 0.360 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 63 | 0.350 |
Why?
|
| Humans | 51 | 2023 | 58880 | 0.350 |
Why?
|
| Treatment Outcome | 13 | 2022 | 5100 | 0.350 |
Why?
|
| Dogs | 1 | 2011 | 308 | 0.350 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2015 | 106 | 0.340 |
Why?
|
| Adolescent | 19 | 2018 | 5871 | 0.340 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 38 | 0.330 |
Why?
|
| Retrospective Studies | 15 | 2022 | 5922 | 0.320 |
Why?
|
| Male | 29 | 2021 | 27286 | 0.300 |
Why?
|
| Thoracoscopy | 3 | 2004 | 19 | 0.300 |
Why?
|
| Laparoscopes | 1 | 2007 | 21 | 0.290 |
Why?
|
| Touch | 1 | 2007 | 28 | 0.290 |
Why?
|
| Jejunal Diseases | 1 | 2007 | 8 | 0.290 |
Why?
|
| Choristoma | 1 | 2007 | 23 | 0.280 |
Why?
|
| Intussusception | 1 | 2007 | 12 | 0.280 |
Why?
|
| Stomach | 1 | 2007 | 84 | 0.280 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 124 | 0.270 |
Why?
|
| Sternum | 1 | 2006 | 26 | 0.270 |
Why?
|
| Spleen | 2 | 2012 | 485 | 0.260 |
Why?
|
| Female | 27 | 2018 | 30581 | 0.260 |
Why?
|
| Thoracic Wall | 1 | 2006 | 16 | 0.260 |
Why?
|
| Sutures | 2 | 2016 | 33 | 0.260 |
Why?
|
| Infant, Newborn | 12 | 2022 | 1302 | 0.260 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 140 | 0.260 |
Why?
|
| Urethral Diseases | 1 | 2005 | 3 | 0.260 |
Why?
|
| Urinary Fistula | 1 | 2005 | 8 | 0.260 |
Why?
|
| Anus, Imperforate | 1 | 2005 | 4 | 0.260 |
Why?
|
| Urethra | 1 | 2005 | 16 | 0.250 |
Why?
|
| Catheterization, Central Venous | 2 | 1997 | 85 | 0.250 |
Why?
|
| Rectal Fistula | 1 | 2005 | 14 | 0.250 |
Why?
|
| Colonic Diseases | 1 | 2005 | 34 | 0.250 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 1446 | 0.220 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 28 | 0.200 |
Why?
|
| Musa | 1 | 2021 | 6 | 0.200 |
Why?
|
| Hypocalcemia | 1 | 2022 | 16 | 0.200 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.200 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.200 |
Why?
|
| Stomach Volvulus | 1 | 2001 | 3 | 0.200 |
Why?
|
| Splenic Diseases | 1 | 2001 | 14 | 0.190 |
Why?
|
| Intestinal Atresia | 1 | 2001 | 2 | 0.190 |
Why?
|
| Duodenal Obstruction | 1 | 2001 | 4 | 0.190 |
Why?
|
| Common Bile Duct | 1 | 2001 | 19 | 0.190 |
Why?
|
| Esophageal Atresia | 2 | 2004 | 10 | 0.190 |
Why?
|
| Length of Stay | 4 | 2015 | 760 | 0.190 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2316 | 0.180 |
Why?
|
| Boston | 1 | 2022 | 326 | 0.180 |
Why?
|
| Physician Assistants | 1 | 2020 | 37 | 0.180 |
Why?
|
| Pediatricians | 1 | 2020 | 38 | 0.170 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 115 | 0.170 |
Why?
|
| Lung | 1 | 2004 | 819 | 0.160 |
Why?
|
| Appendix | 1 | 2018 | 13 | 0.160 |
Why?
|
| Pediatrics | 1 | 2021 | 252 | 0.160 |
Why?
|
| Cell Respiration | 1 | 2018 | 21 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2016 | 1114 | 0.150 |
Why?
|
| Fibroblasts | 2 | 1997 | 366 | 0.150 |
Why?
|
| Hospital Mortality | 2 | 2013 | 840 | 0.150 |
Why?
|
| Phytotherapy | 1 | 2018 | 52 | 0.150 |
Why?
|
| Hypertension, Renal | 1 | 1997 | 3 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 112 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2018 | 85 | 0.140 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1997 | 7 | 0.140 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 15 | 0.140 |
Why?
|
| Parenteral Nutrition | 1 | 1997 | 21 | 0.140 |
Why?
|
| Pharynx | 1 | 1997 | 20 | 0.140 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 24 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2018 | 159 | 0.140 |
Why?
|
| Hematoma | 1 | 1997 | 73 | 0.140 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 75 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 487 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 447 | 0.130 |
Why?
|
| Blood Proteins | 1 | 1996 | 72 | 0.130 |
Why?
|
| Esophagostomy | 1 | 1996 | 1 | 0.130 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1996 | 24 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 402 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 63 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 1996 | 55 | 0.130 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 129 | 0.130 |
Why?
|
| Postoperative Care | 1 | 1996 | 112 | 0.130 |
Why?
|
| Pancreas | 1 | 2015 | 145 | 0.120 |
Why?
|
| Kidney | 1 | 1997 | 391 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 893 | 0.120 |
Why?
|
| Age Factors | 3 | 2013 | 1517 | 0.120 |
Why?
|
| Incidence | 3 | 2013 | 1226 | 0.110 |
Why?
|
| Drainage | 2 | 2011 | 144 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2013 | 770 | 0.110 |
Why?
|
| Soft Tissue Infections | 2 | 2011 | 42 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 53 | 0.100 |
Why?
|
| Community-Acquired Infections | 2 | 2011 | 87 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 637 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.100 |
Why?
|
| Firearms | 1 | 2013 | 60 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 48 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 28 | 0.100 |
Why?
|
| Neutropenia | 1 | 2012 | 66 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1441 | 0.100 |
Why?
|
| Rectum | 2 | 2005 | 82 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 256 | 0.100 |
Why?
|
| Equipment Design | 2 | 2007 | 313 | 0.100 |
Why?
|
| Appendectomy | 2 | 2018 | 48 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 2444 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 17 | 0.100 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 40 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Ureteroscopy | 1 | 2011 | 3 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 370 | 0.090 |
Why?
|
| Operating Rooms | 1 | 2011 | 53 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 485 | 0.090 |
Why?
|
| Esophagus | 2 | 2004 | 51 | 0.090 |
Why?
|
| Emergencies | 1 | 2011 | 113 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2011 | 84 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 64 | 0.090 |
Why?
|
| Acute Disease | 1 | 2012 | 654 | 0.090 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 13 | 0.090 |
Why?
|
| Surgical Stapling | 1 | 2010 | 11 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 163 | 0.090 |
Why?
|
| Gastroscopy | 1 | 2010 | 24 | 0.090 |
Why?
|
| Gastrostomy | 1 | 2010 | 33 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1537 | 0.080 |
Why?
|
| Herniorrhaphy | 2 | 2022 | 64 | 0.080 |
Why?
|
| United States | 5 | 2022 | 7441 | 0.080 |
Why?
|
| Splenectomy | 2 | 2012 | 40 | 0.070 |
Why?
|
| Bacteriuria | 1 | 2007 | 11 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 86 | 0.070 |
Why?
|
| Funnel Chest | 1 | 2005 | 7 | 0.060 |
Why?
|
| Wound Healing | 2 | 2016 | 175 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2005 | 33 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2005 | 11 | 0.060 |
Why?
|
| Prostatic Diseases | 1 | 2005 | 7 | 0.060 |
Why?
|
| Gynecomastia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2005 | 48 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2005 | 14 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 711 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2005 | 19 | 0.060 |
Why?
|
| Colostomy | 1 | 2005 | 23 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 68 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 575 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 20 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2005 | 21 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 26 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2007 | 3077 | 0.060 |
Why?
|
| Esophagoplasty | 1 | 2004 | 4 | 0.060 |
Why?
|
| Insufflation | 1 | 2004 | 10 | 0.060 |
Why?
|
| Animals | 4 | 2016 | 19498 | 0.060 |
Why?
|
| Pressure | 1 | 2004 | 74 | 0.060 |
Why?
|
| Hand Injuries | 1 | 2003 | 11 | 0.060 |
Why?
|
| Models, Animal | 1 | 2004 | 219 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 337 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 43 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 72 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2563 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 372 | 0.050 |
Why?
|
| Fundoplication | 1 | 2002 | 18 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 29 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 35 | 0.050 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 12 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 925 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2022 | 4 | 0.050 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 8 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 9 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2022 | 32 | 0.050 |
Why?
|
| Cisplatin | 1 | 2002 | 119 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2002 | 97 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 29 | 0.050 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2001 | 24 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2001 | 35 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2022 | 78 | 0.050 |
Why?
|
| Mouth Diseases | 1 | 2001 | 15 | 0.050 |
Why?
|
| Laparotomy | 1 | 2001 | 45 | 0.050 |
Why?
|
| Cysts | 1 | 2001 | 37 | 0.050 |
Why?
|
| Urogenital System | 1 | 2001 | 2 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2013 | 1893 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2015 | 830 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 1245 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2001 | 94 | 0.050 |
Why?
|
| Adult | 6 | 2007 | 15609 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 125 | 0.040 |
Why?
|
| Fetus | 2 | 2001 | 97 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 505 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 275 | 0.040 |
Why?
|
| Birth Injuries | 1 | 1998 | 2 | 0.040 |
Why?
|
| Rectovaginal Fistula | 1 | 1998 | 3 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 6 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 396 | 0.040 |
Why?
|
| Cytotoxins | 1 | 2018 | 12 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 22 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 27 | 0.040 |
Why?
|
| Rhodiola | 1 | 2018 | 15 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 531 | 0.040 |
Why?
|
| Rectal Diseases | 1 | 1998 | 26 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 45 | 0.040 |
Why?
|
| Vagina | 1 | 1998 | 82 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1997 | 15 | 0.040 |
Why?
|
| Collagen | 1 | 1997 | 120 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 103 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2010 | 84 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 445 | 0.030 |
Why?
|
| Esophageal Achalasia | 1 | 1997 | 29 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 198 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 547 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1996 | 2 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 11 | 0.030 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1996 | 4 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1996 | 21 | 0.030 |
Why?
|
| Exercise | 1 | 2003 | 902 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1996 | 30 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 180 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 709 | 0.030 |
Why?
|
| Gestational Age | 1 | 1996 | 181 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 103 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2429 | 0.030 |
Why?
|
| Ischemia | 1 | 1997 | 188 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2042 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 234 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1360 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 936 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 630 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 910 | 0.030 |
Why?
|
| Urban Population | 1 | 2013 | 182 | 0.030 |
Why?
|
| Young Adult | 2 | 2013 | 4279 | 0.030 |
Why?
|
| Cell Line | 1 | 1996 | 2011 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 2013 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 286 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 254 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 261 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 780 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 957 | 0.020 |
Why?
|
| Clavulanic Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Ticarcillin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 13 | 0.020 |
Why?
|
| Penicillins | 1 | 1989 | 28 | 0.020 |
Why?
|
| Gentamicins | 1 | 1989 | 22 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 221 | 0.020 |
Why?
|
| Retreatment | 1 | 2009 | 45 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1989 | 139 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2005 | 34 | 0.020 |
Why?
|
| Mastectomy, Simple | 1 | 2005 | 2 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 130 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2004 | 26 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 232 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 157 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 94 | 0.010 |
Why?
|
| Contracture | 1 | 2003 | 7 | 0.010 |
Why?
|
| Finger Injuries | 1 | 2003 | 12 | 0.010 |
Why?
|
| Accidents, Home | 1 | 2003 | 12 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 82 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 13221 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 151 | 0.010 |
Why?
|
| Pregnancy | 2 | 2001 | 2334 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 512 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 76 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2001 | 5 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2001 | 45 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 43 | 0.010 |
Why?
|
| Circumcision, Male | 1 | 2001 | 8 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 107 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2002 | 171 | 0.010 |
Why?
|
| Placenta | 1 | 2001 | 60 | 0.010 |
Why?
|
| Massachusetts | 1 | 2005 | 2078 | 0.010 |
Why?
|
| Breech Presentation | 1 | 1998 | 1 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1998 | 232 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1997 | 22 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 142 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1998 | 172 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 162 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 473 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1997 | 362 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 498 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1998 | 521 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 4975 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 1151 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 2090 | 0.010 |
Why?
|
| Abdomen | 1 | 1989 | 89 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1989 | 432 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 662 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 5046 | 0.000 |
Why?
|
| Middle Aged | 1 | 1989 | 16134 | 0.000 |
Why?
|